Venture funding fuels University of Hawaii tech innovation
from UH System Current News
The Upside Fund, a venture capital fund managed by the University of Hawaii Foundation in conjunction with the Hawai'i Strategic Development Corporation and the Research Corporation of the University of Hawaii has invested $100,000 to help launch Protekai, Inc. Formed by Omar S. Sultan, Protekai, Inc. commercializes intellectual property developed in Angel Yanagihara's, Ph.D., research laboratory. Yanagihara is a researcher in the Department of Tropical Medicine, Medical Microbiology and Pharmacology in the University of Hawaii Mānoa's John A. Burns School of Medicine. During the course of 12 years of research, Yanagihara has discovered and patented Physalia Fluorescent Proteins. These proteins have the potential to create powerful new biomedical research and diagnostic tools.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063